Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.16.2 (
PCP
)
3,761
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The RNA polymerase gene of murine coronavirus MHV-JHM encodes a polyprotein of greater than 750 kDa. This polyprotein is proposed to be processed by two papain-like cysteine proteinases,
PCP
-1 and
PCP-2
, and a poliovirus 3C-like proteinase domain, 3C-pro, to generate protein products. The amino-terminal product of the MHV polymerase polyprotein, p28, is generated by cleavage of the polyprotein by
PCP
-1. To identify the viral products downstream of p28, we generated a fusion-protein specific antiserum directed against the region adjacent to p28 and used the antiserum to detect virus-specific proteins from MHV-JHM infected cells. When this antiserum was used to immunoprecipitate radiolabeled proteins from MHV-JHM infected cell lysates, virus-specific proteins of 72 and 65 kDa were detected. Furthermore, pulse and chase experiments demonstrated that p72 is likely a precursor to the mature protein product, p65. To investigate which viral proteinase may be responsible for generating p72 and p65, we expressed the 5'-region of the MHV-JHM RNA polymerase gene including the two papain-like cysteine proteinase domains in an in vitro transcription/translation system and analyzed the translation products for proteolytic processing. We also cloned and expressed the 72 kDa region immediately downstream from p28, and tested the ability of in vitro translated
PCP
-1 and
PCP-2
to cleave p72 to p65 in trans. Our results indicate that neither viral proteinase domain
PCP
-1 nor
PCP-2
is capable of cleavage of p72 to produce p65 in vitro. The role of MHV proteinases in the processing of p72 and p65 is discussed.
...
PMID:Identification of the polymerase polyprotein products p72 and p65 of the murine coronavirus MHV-JHM. 889 45
1. The activity of Ca2+ channels is regulated by a number of mechanisms including direct allosteric modulation by intracellular ATP. Since ATP derived from glycolysis is preferentially used for membrane function, we hypothesized that glycolytic ATP also preferentially regulates cardiac L-type Ca2+ channels. 2. To test this hypothesis, peak L-type Ca2+ currents (ICa) were measured in voltage-clamped rabbit cardiomyocytes during glycolytic inhibition (2-deoxyglucose + pyruvate), oxidative inhibition (cyanide + glucose) or both (full metabolic inhibition;
FMI
). 3. A 10 min period of
FMI
resulted in a 40.0 % decrease in peak ICa at +10 mV (-5.1 +/- 0.6 versus -3.1 +/- 0.4 pA pF-1; n = 5, P < 0.01). Similar decreases in peak ICa were observed during glycolytic inhibition using 2-deoxyglucose (-6.2 +/- 0.2 versus -3.7 +/- 0.2 pA pF-1; n = 5, P < 0.01) or iodoacetamide (-6.7 +/- 0.3 versus -3.7 +/- 0.2 pA pF-1; n = 7, P < 0.01), but not following oxidative inhibition (-6.2 +/- 0.4 versus -6.4 +/- 0.3 pA pF-1; n = 5, n.s.). The reduction in ICa following glycolytic inhibition was not mediated by phosphate sequestration by 2-deoxyglucose or changes in intracellular pH. 4. Reductions in ICa were still observed when inorganic phosphate and creatine were included in the pipette, confirming a critical role for glycolysis in ICa regulation. 5. With 5 mM MgATP in the pipette during
FMI
, peak ICa decreased by only 18.4 % (-6.8 +/- 0.6 versus -5.5 +/- 0.3 pA pF-1; n = 4, P < 0.05), while inclusion of 5 mM MgAMP-
PCP
(beta,gamma-methyleneadenosine 5'-triphosphate, Mg2+ salt) completely prevented the decrease in peak ICa (-6.9 +/- 0.3 versus -6.5 +/- 0.3 pA pF-1; n = 5, n.s.). 6. Together, these results suggest that ICa is regulated by intracellular ATP derived from glycolysis and does not require hydrolysis of ATP. This regulation is expected to be energy conserving during periods of metabolic stress and myocardial ischaemia.
...
PMID:Preferential regulation of rabbit cardiac L-type Ca2+ current by glycolytic derived ATP via a direct allosteric pathway. 967 64
The synthesis of three- and four-layered [3.3]paracyclophanes ([3.3]PCPs) 3-5 has been accomplished by utilizing the (p-ethylbenzenesulfonyl)methyl isocyanide (EbsMIC) method. The structures of the three- to four-layered [3.3]PCPs 3- 5 and their diones 8, 10, and 11 have been elucidated based on the (1)H NMR spectra and finally by X-ray structural analysis. In the three-layered [3.3]
PCP
-dione 8, the trimethylene bridges of the [3.3]
PCP
unit assume a chair conformation similar to that of 2, while the [3.3]
PCP-2
,11-dione unit assumes a boat conformation different from that of [3.3]
PCP
-dione 1 with a chair conformation. On the other hand, the two [3.3]
PCP
units in three-layered [3.3]
PCP
3 both assume a boat conformation. In the four-layered [3.3]
PCP
-dione 10, the two outer [3.3]
PCP
units assume a boat conformation while the inner dione unit has a chair conformation. The trimethylene bridges in the four-layered [3.3]
PCP
4 are highly disordered even at -150 degrees C. All the outer benzene rings are distorted into a boat form while the inner ones are distorted into a twist form. In the electronic spectra, bathochromic shift and hyperchromic effect are observed, but the magnitude decreases with an increase in the number of layers and the spectra become structureless. In the charge-transfer (CT) bands of the three- to four-layered [3.3]PCPs 3- 5 with tetracyanoethylene (TCNE), two absorption maxima (lambda(max)) are observed. The effect of an increase in the layers becomes significant, and the changes in the longest wavelength lambda(max) values from two to three and three to four are ca. 60 and 50 nm, respectively. By comparison of the stereoisomeric four-layered [3.3]PCPs 4 (meso) and 5 (racemic), the helical arrangement of the trimethylene bridges of 5 shows a more efficient transannular pi-electronic interaction. In the three- to four-layered [3.3]
PCP
-diones, a magnitude of the CT interaction almost comparable to that of [3.3]
PCP
2 was observed, and this indicates that the -CH(2)COCH(2)- bridges inhibit the CT interaction and that this tendency is supported by the calculated HOMO energy levels and observed oxidation potentials. Three- and four-layered [3.3]PCPs 3- 5 show reversible redox processes, and 4 and 5 show an electron-donating ability almost comparable to that of [3 6]CP. Very good correlation between the lambda(max) of the CT bands with TCNE and the oxidation potentials is observed.
...
PMID:Synthesis, structure, and transannular pi-pi interaction of three- and four-layered [3.3]paracyclophanes. 1849 96
Three types of the donor(D)-donor'(D')-acceptor(A) triads 1-6 with different D-A combinations, carbazole (Cz, D)-[n.n]
PCP
(D')-1,8-naphthalimide (NI, A) (1-3), 10H-phenothiazine (PTZ, D)-[n.n]
PCP
(D')-NI(A) (4, 5), and 10-methyl-10H-phenothiazine (Me-PTZ, D)-[2.2]
PCP-2
,1,3-benzothiadiazole (BTD, A) 6, were synthesized for the elucidation of their photophysical properties. The absorption spectra and electrochemical properties indicated that the chromophores (D, D', and A) do not interact with each other in the ground state. Cz-(CH2)3-[2.2]
PCP
-(CH2)3-NI 1 and Cz-(CH2)3-[3.3]
PCP
-(CH2)3-NI 2 show an exciplex emission between the
PCP
and NI moieties in cyclohexane and the intensity of the band is much higher in 2 than in 1, whereas Cz-(CH2)2-[2.2]
PCP
-(CH2)2-NI 3 does not show any exciplex emission in cyclohexane. These results indicated that the combination of [3.3]
PCP
and a trimethylene chain is preferable for the exciplex formation. PTZ-(CH2)3-[2.2]
PCP
-(CH2)3-NI 4 shows a broad band at 519 nm in cyclohexane, which is associated with the formation of the exterplex band among the NI, [2.2]
PCP
, and PTZ moieties, while PTZ-(CH2)3-[3.3]
PCP
-(CH2)3-NI 5 does not show the band. Me-PTZ-(CH2)2-[2.2]
PCP
-(CH2)2-BTD 6 shows a broad fluorescence band due to both the BTD and PTZ moieties in cyclohexane. In CH3CN, the fluorescence spectra of 1-6 suggest the presence of a photoinduced charge separation process. The study of the photoinduced charge separation process will be soon reported elsewhere.
...
PMID:Synthesis and electronic and photophysical properties of [2.2]- and [3.3]paracyclophane-based donor-donor'-acceptor triads. 2536 Dec 29